A specialty phospholipid R&D programme developing high-purity plasmalogen (Pls) monomers via microbial enzymatic synthesis. Plasmalogens are membrane phospholipids implicated in membrane fluidity and free-radical scavenging — pathways associated with age-related cognitive decline.
The pipeline targets functional food, supplement and pharmaceutical formats, with a clinical Phase 1–3 pathway under design. The lab partnership is led with Prof. Tian at Zhejiang University.
Cognitive-health ingredients with credible mechanisms and manufacturable supply are scarce. The programme's emphasis on enzymatic synthesis and a staged regulatory pathway is designed to turn a promising molecule into a compliant, scalable product.